Sonoco Products Company
5.7.2017 16:20 | Nasdaq OMX
Sonoco-Alcore to Increase Paperboard Prices in Europe
BRUSSELS, Belgium, July 05, 2017 (GLOBE NEWSWIRE) -- Sonoco-Alcore S.a.r.l. today announced it will again raise prices by a further €50 per tonne (£40 / tonne) on all recycled paperboard grades sold in the Company's European regions. The price change is effective with shipments on or after 17th July 2017.
"Demand for raw materials has continued to rise throughout the year as a result of China's "National Sword" initiative, new capacity within the paper packaging sector, and the European economy currently being stronger than we have seen in recent years. The resultant continued increase in raw material costs are again unsustainable and we now have no choice but to pass these increases through into the market," said Phil Woolley, Director - Paper Europe.
Sonoco-Alcore S.a.r.l. is wholly owned by Sonoco (NYSE:SON) and operates 29 tubes and cores plants and four paperboard mills in Europe, including the Company's largest European uncoated recycled paperboard mill in Cirie, Italy.
Information om Nasdaq OMX
Følg pressemeddelelser fra Nasdaq OMX
Ved at skrive dig op her, vil du modtage pressemeddelelser på mail når de udsendes. Indtast din mail og følg instruktionerne. Det er ligeså let at melde sig fra igen.
Flere pressemeddelelser fra Nasdaq OMX
Cority Software Inc.25.7.2017 16:01 | pressemeddelelse
Cority (formerly Medgate) Moves Up in The Leaders Quadrant of the 2017 EHS Software Green Quadrant
RedHill Biopharma Ltd.25.7.2017 13:23 | pressemeddelelse
RedHill Biopharma Reports 2017 Second Quarter Financial Results
Compuware Corporation25.7.2017 12:01 | pressemeddelelse
Compuware and Wipro Jointly Launch a Mainframe Center of Excellence
VITEC25.7.2017 10:32 | pressemeddelelse
VITEC to Showcase Field-Proven Military and Defense Video Streaming Solutions at DSEI
Nasdaq25.7.2017 09:01 | pressemeddelelse
Nasdaq to Acquire Sybenetix
Novavax, Inc.24.7.2017 22:07 | pressemeddelelse
Novavax Announces Positive Topline Data from Phase 2 Older Adult Trial and Provides Path Forward for RSV F Vaccine Programs
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum